Impact of Pulmonary Rehabilitation on Exercise Tolerance and Quality of Life in Patients with Idiopathic Pulmonary Fibrosis A SYSTEMATIC REVIEW and META-ANALYSIS

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 38, Issue 5, 2018, Pages 273-278

  Gomes Neto, Mansueto ^a   Silva, Cassio Magalhães ^a   Ezequiel, Diego ^b   Conceição, Cristiano Sena ^a   Saquetto, Micheli ^a   MacHado, Adelmir Souza ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Department of Physical Therapy ^*  (Brazil)

Author keywords

Exercise; idiopathic pulmonary fi brosis; quality of life

Indexed keywords

6 MINUTE WALK DISTANCE; ASSESSMENT OF HUMANS; BASELINE DYSPNEA INDEX; CARDIOPULMONARY EXERCISE TEST; EXERCISE TOLERANCE; FIBROSING ALVEOLITIS; FOLLOW UP; HEART RATE; HUMAN; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; MAXIMAL INSPIRATORY PRESSURE; MAXIMUM PREDICTED HEART RATE; META ANALYSIS; MODIFIED MEDICAL RESEARCH COUNCIL QUESTIONNAIRE; PEAK OXYGEN UPTAKE; PEDRO; PHYSICAL PARAMETERS; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYSTEMATIC REVIEW; WALKING DISTANCE; WORK RATE; PATHOPHYSIOLOGY;

EXERCISE TOLERANCE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85061724696     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0000000000000273     Document Type: Review

References (34)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000;161: 646-664
2. King T, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378: 1949-1961
3. Nishiyama O, Taniguchi H, Kondoh Y, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med. 2005;99: 408-414
4. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax. 2005;60: 588-594
5. Rafi R, Juarez MM, Albertson TE, Chan AL. A review of current and novel therapies for idiopathic pulmonary fibrosis. J Thorac Dis. 2013;5: 48-73
6. Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008;102: 1675-1680
7. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188: e13-e64
8. Rammaert B, Leroy S, Cavestri B, Wallaert B, Grosbois JM. Homebased pulmonary rehabilitation in idiopathic pulmonary fibrosis Rev Mal Respir. 2011;28: e52-e57. doi:10.1016/j.rmr.2011.06.006.
9. Huppman P, Sczepansk B, Boensch M, et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease Eur Respir J. 2013;42: 444-453
10. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183: 788-824
11. Kenn K, Gloeckl R, Behr J. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis-a review. Respiration 2013;86: 89-99
12. Moher D, Liberati A, Tetzlaff J. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339: b2535
13. Higgins JPT, Green S. Cochrane handbook for Systematic Reviews of Interventions 4.2.6 [update September 2006]. The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons; 2006
14. Olivo SA, Macedo LG, Gadotti IN, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther. 2008;88: 156-175
15. Verhagen AP, de Vet HCW, de Bie RA, Kessels AGH, et al. The Delphi List: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi Consensus. J Clin Epidemiol. 1998;51: 1235-1241
16. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M Reliability of the PEDro scale for rating of quality randomized controlled trials. Phys Ther. 2003;83: 713-721
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327 (7414): 557-560
18. Cochrane Collaboration home page. www.cochrane.org. Accessed February 3, 2008
19. Vainshelboim B, Oliveira J, Fox BD, Soreck Y, Fruchter O, Kramer MR. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung 2015;193: 345-354
20. Jackson RM, Gomez-Marin OW, Ramos CF, et al. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung. 2014;192: 367-376
21. Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise training-based pulmonary rehabilitation program is clinically benefi cial for idiopathic pulmonary fibrosis. Respiration. 2014;88(5):378-388
22. Gaunaurd IA, Gómez-Marín OW, Ramos CF, et al. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program Respir Care. 2014;59: 1872-1879
23. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13: 394-399
24. Fell CD, Liu LX, Motika C, et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179: 402-407
25. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med. 2009;103: 117-123
26. Du Bois RM, Albera C, Bradford WZ, et al. 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014;43: 1421-1429
27. Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM. Six minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174: 659-664
28. Swigris JJ, Esser D, Conoscenti CS, Brown KK. The psychometric properties of the St. George's Respiratory Questionnaire [SGRQ] in patients with idiopathic pulmonary fibrosis: a literature review Health Qual Life Outcomes. 2014;12: 124
29. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;(2): CD003793 doi:10.1002/14651858.CD003793.pub3.
30. Babu AS, Padmakumar R, Maiya AG, Mohapatra AK, Kamath RL Effects of exercise training on exercise capacity in pulmonary arterial hypertension: a systematic review of clinical trials. Heart Lung Circ 2016;25: 333-341
31. Wang H, Liu X, Rice SJ, Belani CP. Pulmonary rehabilitation in lung cancer. PM R. 2016;8: 990-996
32. Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fi tness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011;43: 1334-1359
33. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355: 362-368
34. Foglio K, Bianchi L, Bruletti G, et al. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med. 2007;101: 1961-1970